Alcon - Governance - Board of Directors
2021 Annual Report Wrapper
Alcon - Governance - Board of Directors
F. Michael Ball Net Worth (2023) | wallmine
Mike Ball, Alcon Inc: Profile and Biography - Bloomberg Markets
PR%F the Magazine June 2022 by Food & Beverage Magazine - Issuu
Alcon CEO And Leadership: Executives and Demographics - Zippia
Alcon becomes a separately traded standalone company | Novartis
Michael F. Land - Wikipedia
F. Michael Ball — CEO, Alcon at Novartis | Comparably
Alcon CEO And Leadership: Executives and Demographics - Zippia
Alcon - Governance - Board of Directors
Alcon becomes a separately traded standalone company | Novartis
Michael Onuscheck Net Worth (2023) | wallmine
Alcon - Governance - Board of Directors
Alcon Announces Results of 2023 Annual General Meeting
Spotlight On... Novartis' troubled Alcon unit recalls eye drops for sterility, potency problems; Endo tanks on women's health sale; AZ sells rights to constipation drug; Denmark vies for EMA; and more...
Alcon CEO And Leadership: Executives and Demographics - Zippia
Thomas Glanzmann - Director at Alcon | The Org
Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3T4T5OVXSBPCFG3X5KLSKUSBI4.jpg "ALCC.S - | Stock Price & Latest News | Reuters")
ALCC.S - | Stock Price & Latest News | Reuters
17. Alcon (Novartis AG) | Medical Product Outsourcing
Aerie raids Alcon again, returning this time with an R&D VP | Fierce Biotech
Michael Ball | LinkedIn
An Investment Review of Alcon Inc. Since Its Spin-off from Novartis
Meet Our Board - Ophthalmology Foundation
